Nanoviricides Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Employees
  • 17
Employees
  • Stock Symbol
  • NNVC
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $6.15
  • (As of Thursday Closing)

Nanoviricides General Information

Description

Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
ASE
Primary Office
  • 1 Controls Drive
  • Suite 205
  • Shelton, CT 06484
  • United States
+1 (203) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanoviricides Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.15 $6.56 $1.27 - $19.20 $65.5M 10.6M 1.5M -$3.08

Nanoviricides Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018 FY 2017 30-Jun-2017
EV 42,963 14,185 19,740 72,729
Revenue 0 0 0 0
EBITDA (13,060) (7,784) (7,439) (7,574)
Net Income (13,784) (8,424) (8,563) (10,304)
Total Assets 16,528 13,449 18,546 27,003
Total Debt 1,181 0 298 3,956
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nanoviricides Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nanoviricides‘s full profile, request access.

Request a free trial

Nanoviricides Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing and commercializing th
Biotechnology
Shelton, CT
17 As of 2019
000.00
000000000 000.00

00000 00

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000 000000000
San Francisco, CA
00 As of 0000
00000
000000000 00000

0000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000 000000000
South San Francisco, CA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanoviricides Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eidos Therapeutics Formerly VC-backed San Francisco, CA 00 00000 000000000 00000
0000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
000000 (0000 00000 Angel-Backed New York, NY 0 00000 0000000000 00000
000000 0000 000000 Corporation New York, NY 00 000.00 000000 - 000 000.00
00000000 Formerly VC-backed Waltham, MA 00 00000 000000&0 00000
You’re viewing 5 of 33 competitors. Get the full list »

Nanoviricides Executive Team (4)

Name Title Board Seat Contact Info
Anil Diwan Ph.D Chief Executive Officer & Chairman
Meeta Vyas Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
To view Nanoviricides’s complete executive team members history, request access »

Nanoviricides Board Members (6)

Name Representing Role Since
0000 00000 00.0 Nanoviricides Chief Executive Officer & Chairman 000 0000
0000 000 00.0 Nanoviricides Board Member 000 0000
0000 000000 Nanoviricides Board Member 000 0000
You’re viewing 3 of 6 board members. Get the full list »

Nanoviricides Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanoviricides Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000-00000 (0000-0 07-Jan-2015 000000000 00000 00 Buildings and Property 000000 0000000
To view Nanoviricides’s complete investments history, request access »